New scan could sharpen prostate cancer detection
NCT ID NCT07162779
Summary
This study is testing a new imaging agent called [68Ga]DOTA-IR-780-C-4 to see if it can help doctors better see prostate cancer tumors and where they have spread. It is for men with a specific type of advanced prostate cancer that has stopped responding to standard hormone treatments. The agent is injected before a PET scan and is designed to stick to prostate cancer cells, making them light up more clearly on the images.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PET-CT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangnan University Affiliated Hospital
Wuxi, Jiangsu, 214026, China
Conditions
Explore the condition pages connected to this study.